Tumor‐derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro
Hepatocellular carcinoma (HCC) remains a global challenge due to high morbidity and mortality rates and poor response to treatment. Immunotherapy, based on introduction of dendritic cells (DCs) activated by tumor cell lysates as antigens ex vivo , shows limited response rates in HCC patients. Here,...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | 英语 |
| 出版: |
2016
|
| 在線閱讀: | https://doi.org/10.1002/hep.28549 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|